Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

Read more

 

MC Services AG is supporting BIO-Europe & German Equity Forum as media partner

 

BIO-Europe 2017 

 

Organized by EBD Group, the 23rd annual BIO-Europe will this year take place in Berlin, Germany, from November 6 to 8, 2017. As Europe's largest life science partnering conference, BIO-Europe is the "must-attend" event offering opportunities for those involved in the biotech industry to network, bringing together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more.

 

As media partner, MC Services invites both local and international journalist to the event and keeps them informed on the presenting company executives and attending investors. Additional Information on MC Services’ engagement and activities during the conference will be announced soon.

 

Learn more


German Equity Forum 2017

 

MC Services AG is again supporting this year’s German Equity Forum, taking place from November 27-29, as media partner.  According to the slogan "Entrepreneurs meet investors" the Deutsche Börse AG has organized the German Equity Forum since 1996, which has evolved into one of the most important and significant capital market events in corporate finance in Europe. Last year alone, around 3,000 1on1 meetings and 200 analysts' conferences took place. The 3-day program features panel discussions, presentations and workshops on current market developments in corporate financing and the capital market.

 

Learn more

ABIVAX First-Half 2017 Financial Results and Update

www.abivax.com

ABIVAX receives French regulatory Approval to Begin Clinical Trial of ABX464 in Ulcerative Colitis

www.abivax.com

WILEX AG: Subsidiary Heidelberg Pharma to Present the Proprietary ATAC Technology Platform at the Annual World ADC Summit

www.wilex.com

NOXXON issues second tranche of ODIRNANE bonds

www.noxxon.com

TxCell to hold conference call on Friday, September 22, 2017 following the publication of its first-half 2017 financial results

www.txcell.com

Pharnext Amends the Protocol of the International Pivotal Phase 3 Trials of PXT3003 for Charcot-Marie-Tooth Disease Type 1A

www.pharnext.com

RedHill Biopharma Receives Notice of Allowance for a New U.S. Patent Covering its Combination Therapy for Hard-to-Treat Cancers

www.redhillbio.com

RedHill Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference

www.redhillbio.com

FIRST PATIENT DOSED IN THREE-MONTH COHORT OF PHASE 2A STUDY OF ORAL ABX464 IN HIV-SUPPRESSED PATIENTS

www.abivax.com

Bencard Allergie GmbH: Zulassung zur Durchführung einer Phase-II-Studie mit POLLINEX(R) Quattro Gräser erteilt

www.bencard.de

MedDay Pharmaceuticals GmbH wird am 90. Kongress der Deutschen Gesellschaft für Neurologie in Leipzig teilnehmen

www.medday-pharma.com

Unaudited Interim results for the six months ended 30 June 2017

www.ergomedplc.com

AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit to elucidate Th17 cell biology

www.ayoxxa.com

MorphoSys Announces that its Licensee Janssen received CHMP Positive Opinion for Tremfya(TM) (Guselkumab) Recommending Approval in Europe

www.morphosys.com